Medically Reviewed by Shruthi N, MD on April 09, 2025
When Immunotherapy Stops Working
1/5

When Immunotherapy Stops Working

Immunotherapy has been a game changer for people living with advanced lung cancer. It helps your body's immune system find and destroy cancer cells, even when they try to hide. But it doesn't work for everyone. If you or a loved one is scheduled to have lung cancer immunotherapy, you need to know the warning signs of treatment failure and what to do.

Changes in Your Symptoms
2/5

Changes in Your Symptoms

If you notice that existing symptoms are getting worse or new symptoms are developing, it could be a sign that your immunotherapy is becoming less effective. Tell your doctor if you have pain, more frequent or severe coughing, or trouble breathing. These symptoms may be side effects of the treatment, or they may mean your treatment isn't working.

Understanding Scan Results
3/5

Understanding Scan Results

Your doctor will schedule scans to monitor your cancer's response to immunotherapy. These may show if tumors are shrinking, staying the same size, or growing. Your cancer might look worse on the first CT scan after you start immunotherapy, but it may actually be getting better. Doctors call this "pseudoprogression." Immunotherapy can cause your tumor to swell and look bigger, but it doesn't mean the cancer has progressed.

Follow-Up Scans
4/5

Follow-Up Scans

Your doctor will review your scans and discuss your symptoms. If you feel OK and the doctor thinks you may have pseudoprogression, they'll usually suggest you wait two or three more treatment cycles (about two months) before getting another scan. If you feel worse and the scan shows a larger tumor and new lesions, immunotherapy likely isn't working. The doctor will recommend you stop it and try something else.

Other Treatment Options
5/5

Other Treatment Options

If immunotherapy doesn't work, your doctor will discuss other ways to treat your cancer. These include chemotherapy, targeted drug treatments, and radiation. If these options also fail, your doctor may suggest you take part in a clinical trial. They provide access to cutting-edge treatments that are not yet approved for treating lung cancer. These include checkpoint inhibitors, therapeutic vaccines, and adoptive T-cell transfer.

This content was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.